BAT Releases 2024 First Half Trading Update for June 4th

Jun.05.2024
BAT Releases 2024 First Half Trading Update for June 4th
BAT releases positive trading update for first half of 2024, anticipates accelerated growth in second half. CEO confident in continued performance.

On June 4th, British American Tobacco (BAT) released a trading update for the first half of 2024. The company revealed that its operational performance in the first half of the year met expectations and it expects growth to accelerate in the second half. This is attributed to the launch of innovative products in new business areas, as well as benefits from investment in commercial actions in the US and inventory flow from related wholesale distributors.


The company's CEO Tadeu Marroco stated:


The company's performance to date has been in line with our expectations. We plan to achieve single-digit revenue and operating profit growth on a year-over-year basis by 2024, followed by revenue growth of 3-5% and mid-single-digit adjusted operating profit growth by 2026 (calculated on an organic and fixed exchange rate basis).


The company stated that its e-cigarette brand Vuse maintains a 41.1% global market share in the e-cigarette market, still holding a leading position. In the US market, it occupies a 51.5% market share. However, due to the illegal growth of disposable e-cigarettes, its performance will be affected. The company emphasized that Vuse will introduce a new disposable e-cigarette Vuse Go 2.0 in 2024, expecting sales and revenue to accelerate in the second half of the year.


Furthermore, since January, sales of the heated tobacco category Glo have gradually recovered their market share in key markets, mainly due to positive consumer response to the new product Glo Hyper Pro and improved consumables. Its market share has remained stable in Japan and Italy, while showing strong performance in the AME market (Asia, Middle East, Africa), Poland, and the Czech Republic. In addition, the non-tobacco consumables line VEO has been launched in 17 markets and plans to further expand during the year. The company expects the momentum of Glo's market share to continue and drive revenue improvement in the second half of the year.


Velo's overall market share in key markets has risen to 10.3%, while the market share for modern oral products remains steady at 27.0%. The AME market (Asia, Middle East, Africa) is leading, including mature markets such as Sweden, Denmark, and Norway, as well as emerging markets like the UK and Poland. The re-launched Velo brand in the US has shown promising initial results, with market share in the test market of New York increasing to 13.5%. BAT expects Velo to continue strong financial performance in the first half and full year of 2024.


As previously emphasized, we expect our performance to improve in the second half of the year, primarily due to changes in wholesalers' inventory, our ongoing business investments in the US market, and the phased launch of new products. However, due to macroeconomic pressures and a lack of effective enforcement against the illegal e-cigarette market, revenue and adjusted operating profit in the first half of the year are expected to decline by single digits. Our focus on quality growth is beginning to drive higher returns in all three new categories, especially in heated tobacco and modern oral products. Therefore, we anticipate profitability in the new categories to further improve in the first half and full year.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

PMI’s Smoke-Free Business Accounts for 43% of Net Revenues in Q1 as Full-Year EPS Guidance Rises
PMI’s Smoke-Free Business Accounts for 43% of Net Revenues in Q1 as Full-Year EPS Guidance Rises
On April 22, 2026, Philip Morris International released its first-quarter 2026 results. The report showed net revenues of $10.146 billion, up 9.1% year on year; adjusted diluted EPS of $1.96, up 16.0%; and smoke-free products accounting for 43% of total net revenues. Based on first-quarter performance, the company raised its 2026 full-year adjusted diluted EPS forecast to $8.36 to $8.51, or $8.11 to $8.26 excluding currency.
Apr.23 by 2FIRSTS.ai
PMI U.S. White Paper Calls for Greater Access to FDA-Authorized Smoke-Free Alternatives and Risk-Based Taxation
PMI U.S. White Paper Calls for Greater Access to FDA-Authorized Smoke-Free Alternatives and Risk-Based Taxation
PMI’s U.S. business released a white paper and cited a national online survey showing that 79.00% of Americans surveyed believe more should be done to reduce smoking-related harm. The paper calls on policymakers, public health authorities, and medical professionals to place cigarette smoking back at the center of public health priorities, and recommends broader access to FDA-authorized smoke-free alternatives, clearer nicotine risk communication, and risk-based taxation.
Apr.15 by 2FIRSTS.ai
EVO NXT 2026 Opens in Prague as Global NGP Industry Gathers for Two-Day Event
EVO NXT 2026 Opens in Prague as Global NGP Industry Gathers for Two-Day Event
2026 — EVO NXT 2026 officially opened today in Prague, bringing together manufacturers, brand owners, retailers, and decision-makers from across the global next-generation products (NGP) industry. As the event’s official media partner for the fourth consecutive year, 2Firsts is reporting on site, tracking key developments across the exhibition floor, forum agenda, and broader industry discussions.
Apr.17 by 2FIRSTS.ai
Special Report|U.S.-Facing Retailer Lists RELX Creator Pro 15K: A Chinese Brand Signal Under FDA’s Lower-Priority Enforcement Window
Special Report|U.S.-Facing Retailer Lists RELX Creator Pro 15K: A Chinese Brand Signal Under FDA’s Lower-Priority Enforcement Window
Vapesourcing has listed RELX Creator Pro 15K as “Coming Soon” with U.S. warehouse shipping options; while the page does not show that RELX has entered the U.S. market through official channels or that the product has received FDA authorization, the listing suggests that Chinese brand-led ENDS products are becoming a new point of observation as the U.S. market reassesses regulatory risk following the FDA’s updated enforcement-priority policy.
Industry Insight
Jun.11
2Firsts Hosts U.S. Compliance Briefing on Building PMTA Support Capabilities Across the Nicotine Supply Chain
2Firsts Hosts U.S. Compliance Briefing on Building PMTA Support Capabilities Across the Nicotine Supply Chain
2Firsts held a U.S. compliance briefing in Shenzhen to help vaping, heated tobacco and nicotine pouch supply chain companies strengthen PMTA support capabilities. The event focused on supplier documentation, quality systems, traceability, TPMF/TPMP pathways, age verification and customer audit readiness as U.S. compliance expectations increasingly extend deeper into the nicotine supply chain.
Events
Jun.12
Ukrainian Media: Polish Vape Distributor Evapify Allegedly Linked to Russian Businessman Named in U.S. “Russia Oligarch Report”
Ukrainian Media: Polish Vape Distributor Evapify Allegedly Linked to Russian Businessman Named in U.S. “Russia Oligarch Report”
According to an investigative report by Euromaidan Press, a Ukrainian English-language independent media outlet, Russian businessman Oleg Boyko has been sanctioned by Ukraine, Poland, Australia and Canada, but has not been added to the European Union’s sanctions list. The report alleges that Evapify, a Polish vape distributor with financial and personal ties to Boyko, holds a significant position in Poland’s disposable vape market.
News
Jun.01